PFKFB3 and neoplasm: The selective inhibition of PFKFB3 displays broad anti-tumor activity in syngenic pre-clinical models and early human studies by inducing necroptotic cell death, apoptosis, cell cycle arrest, and inhibiting invasion [99,100].